|
2,000% Drug Price Surge Is a Side Effect of FDA Safety ProgramBloombergOct. 06, 2015 |
Popular 
Report: Blinken Sitting On Staff Recommendations to Sanction Israeli Military Units Linked to Killings or Rapes
America Last: House Bill Provides $26B for Israel, $61B for Ukraine and Zero to Secure U.S. Border
Bari Weiss' Free Speech Martyr Uri Berliner Wants FBI and Police to Spy on Pro-Palestine Activists
'Woke' Google Fires 28 Employees Who Protested Gaza Genocide
John Hagee Cheers Israel-Iran Battle as 'Gog and Magog War,' Will Lobby Congress Not to Deescalate
 Colchicine, a gout remedy so old that the ancient Greeks knew about its effects, used to cost about 25 cents per pill in the U.S. Then in 2010 its price suddenly jumped 2,000 percent. That’s just one of the side effects of a U.S. Food and Drug Administration plan to encourage testing of medicines that have been around longer than the modern FDA itself, and so have never gotten formal approval. Companies that do the tests are rewarded with licenses that can temporarily give them monopoly pricing power as most rivals are eased or kicked off the market. The result has been a surge in the cost of drugs used in treatments from anesthesia to heart surgery and eye operations. Read More 
|
